Melphalan-prednisone versus dexamethasone-based regimens in elderly patients with multiple myeloma ineligible for high-dose therapy

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'Melphalan-prednisone versus dexamethasone-based regimens in elderly patients with multiple myeloma ineligible for high-dose therapy'. Together they form a unique fingerprint.